Equities not available in your region
ABBV icon

AbbVie (ABBV)

NYSE

251,85 $

−2,29 $ (

−0,90 %

)

1D
5D
1M
6M
1Y
5Y
Pre market

ABBV: 251,85 $ / ₿ 0.0043 BTC / 427742 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

254,14 $
184,39 $ - 255,99 $
$ 444,97G
-3.77
9 743,21 $
1,77 md
124.66
252,10 $ - 253,50 $
2.72
Yes

What is AbbVie (ABBV)?

AbbVie är ett läkemedelsföretag med stark exponering mot immunologi (med Humira, Skyrizi och Rinvoq) och onkologi (med Imbruvica och Venclexta). Företaget knoppades av från Abbott i början av 2013. Förvärvet av Allergan 2020 lade till flera nya produkter och läkemedel inom estetik, inklusive Botox. Förvärven av Cerevel (neurovetenskap) och ImmunoGen (onkologi) 2024 bidrar till att komplettera AbbVies portfölj.

The AbbVie (ABBV) stock price has been falling

The ABBVIE INC. (ABBV) stock pre-market price today is 251,85 $, reflecting a −0,90 % pre-market move since the market last closed. The company’s market capitalization stands at $ 444,97G, with a daily trading volume of $ 9,74K shares. The previous closing price was 254,14 $.

Get started with AbbVie (ABBV)

Ready to get started? Follow the steps below, or read our guide on how to buy AbbVie stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy ABBV

Search for ABBV in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy ABBV.

ABBV FAQs

ABBV is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

ABBV is in the Drug Manufacturers - General industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, ABBVIE INC. (ABBV) has traded between a low of 184,39 $ and a high of 255,99 $.

ABBV is in the Drug Manufacturers industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

ABBV’s payout ratio is 3.26. Payout ratio is a financial metric used to measure the proportion of a company's earnings that are paid out as dividends to shareholders.

ABBV’s trailing dividend yield is 2.65. Trailing dividend yield is a financial metric used to measure the return on investment from a company's dividend payments over the past 12 months.

Want to invest in AbbVie? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
ABBV icon
ABBV

Only available to USA clients through the Kraken app
or Kraken Pro.

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

YOTAR icon

YOTAR

JDZG icon

JDZG

YDESW icon

YDESW

AIIOW icon

AIIOW

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.